Trifluoroacetic acid → HCID 44193619, compound
Reaction equation
[CH2:1]([N:3]1[C:7]2=[N:8][C:9]([CH2:32][CH3:33])=[C:10]([CH2:19][NH:20][C:21]([C:23]3[N:28]=C(C(O)=O)C=C[CH:24]=3)=[O:22])[C:11]([NH:12][CH:13]3[CH2:18][CH2:17][O:16][CH2:15][CH2:14]3)=[C:6]2[CH:5]=[N:4]1)[CH3:2].[NH2:34][CH2:35][C:36]1[CH:41]=[CH:40][N:39]=[C:38]([C:42]2[CH:43]=[C:44]([CH2:48][CH:49]3[CH2:54][CH2:53][N:52](C(OC(C)(C)C)=O)[CH2:51][CH2:50]3)[CH:45]=[CH:46][CH:47]=2)[CH:37]=1.CN(C(ON1N=N[C:72]2C=CC=C[C:71]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[C:86]([OH:92])([C:88](F)(F)F)=O>ClCCl>[CH2:1]([N:3]1[C:7]2=[N:8][C:9]([CH2:32][CH3:33])=[C:10]([CH2:19][NH:20][C:21]([C:23]3[CH:24]=[CH:72][CH:71]=[C:88]([C:86]([NH:34][CH2:35][C:36]4[CH:41]=[CH:40][N:39]=[C:38]([C:42]5[CH:47]=[CH:46][CH:45]=[C:44]([CH2:48][CH:49]6[CH2:50][CH2:51][NH:52][CH2:53][CH2:54]6)[CH:43]=5)[CH:37]=4)=[O:92])[N:28]=3)=[O:22])[C:11]([NH:12][CH:13]3[CH2:18][CH2:17][O:16][CH2:15][CH2:14]3)=[C:6]2[CH:5]=[N:4]1)[CH3:2]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To 6-[({[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}amino)carbonyl]-2-pyridinecarboxylic acid (50 mg, 0.110 mmol) was added 1,1-dimethylethyl 4-({3-[4-(aminomethyl)-2-pyridinyl]phenyl}methyl)-1-piperidinecarboxylate (42.2 mg, 0.110 mmol) followed by HBTU (50.3 mg, 0.133 mmol) and TEA (30.8 μl, 0.221 mmol) in dichloromethane (DCM) (1105 μL) to give a reaction mixture. This was stirred at room temperature overnight. Then the reaction was quenched with H2O (1 drop) and the solvent was removed by Glas-Col. The crude product was redissolved in MeOH/DMSO (1/1) and purified using a Gilson HPLC (acidic condition). Product-containing fractions were combined and evaporated by GeneVac EZ-2 evaporator. To this residue was added TFA (0.170 mL, 2.21 mmol) in dichloromethane (0.2 mL) and the mixture was placed in the Glas-Col evaporator overnight. Then it was redissolved in MeOH/DMSO and purified using a Gilson HPLC (acidic condition). Product-containing fractions were combined and evaporated by GeneVac EZ-2 evaporator, basified by cartridge to afford 25.4 mg (31%) of the title compound. LC-MS m/z 716 (M+H)+.
Workup
- customto give a reaction mixture
- customThen the reaction was quenched with H2O (1 drop)
- customthe solvent was removed by Glas-Col
- dissolutionThe crude product was redissolved in MeOH/DMSO (1/1)
- custompurified
- customevaporated by GeneVac EZ-2 evaporator
- customthe mixture was placed in the Glas-Col evaporator overnight
- dissolutionThen it was redissolved in MeOH/DMSO
- custompurified
- customevaporated by GeneVac EZ-2 evaporator
Sources & evidence
- ORD record
- ord-abbb04c98684479e8c0299590464b9db
- Source dataset
- uspto-grants-2011_12
- Patent number
- US08084449B2
Reaction notes
Loading…